Inactive Instrument

Press Releases IsoPlexis Corporation

Equities

ISO

US4650051067

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company	21/23/21	PR
ISOPLEXIS CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	17/23/17	AQ
ISOPLEXIS CORP : Other Events (form 8-K)	10/23/10	AQ
ISOPLEXIS CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	17/23/17	AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNCE, ISO, TIG	15/23/15	PR
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO	15/23/15	BU
SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation	04/23/04	PR
IsoPlexis Reports Preliminary Full Year 2022 Revenue	13/23/13	GL
ISOPLEXIS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	13/23/13	AQ
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO	30/22/30	BU
Berkeley Lights to Acquire IsoPlexis Creating a Premier Functional Cell Biology Company	22/22/22	AQ
Shareholder Alert: Ademi LLP investigates whether IsoPlexis Corporation has obtained a Fair Price in its transaction with Berkeley Lights	22/22/22	PR
ISO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of IsoPlexis Corporation Is Fair to Shareholders	22/22/22	BU
ISOPLEXIS CORP : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22/22/22	AQ
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company	22/22/22	GL
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company	22/22/22	PR
Published in Journal for Immunotherapy of Cancer: Using Single-Cell Analysis to Assess the Effects of an Anti-OX40 Monoclonal Antibody in Its First-in-Human Phase I/II Study for Advanced Solid Cancer	17/22/17	PU
ISOPLEXIS CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	11/22/11	AQ
ISOPLEXIS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/22/10	AQ
IsoPlexis Reports Third Quarter 2022 Financial Results	10/22/10	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IsoPlexis Corporation

Equities

ISO

US4650051067

Press Releases

Filters